Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma-Reference-Cited by-同舟云学术

Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma

Published:2018-01 Issue: Volume:270 Page:158-176
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

de la Puente Pilar,Luderer Micah J.,Federico Cinzia,Jin Abbey,Gilson Rebecca C.,Egbulefu Christopher,Alhallak Kinan,Shah Shruti,Muz Barbara,Sun Jennifer,King Justin,Kohnen Daniel,Salama Noha Nabil,Achilefu Samuel,Vij Ravi,Azab Abdel Kareem

Funder

Multiple Myeloma Research Foundation

National Center for Advancing Translational Sciences

National Institutes of Health

National Cancer Institute

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference76 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Multiple myeloma;Kyle;N. Engl. J. Med.,2004

3. The next generation of novel therapies for the management of relapsed multiple myeloma;Gonsalves;Future Oncol.,2017

4. Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy;Gonsalves;Bone Marrow Transplant.,2016

5. Molecularly targeted therapies in multiple myeloma;de la Puente;Leuk. Res. Treatment,2014

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10

2. IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma;Leukemia;2024-08-30

3. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

4. Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury;American Journal of Transplantation;2024-08

5. Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy;Biomolecules;2024-01-09